FDA Drug Shortages — Page 37
Browse FDA drug shortages by generic name, company and status, with first-posted dates, from the FDA drug shortage database. RegDataLab tracks 1,814 drug shortages from official FDA sources, updated on an ongoing basis.
| Drug shortages | Details |
|---|---|
| Potassium Chloride Tablet, Extended Release | To Be Discontinued — Teva Pharmaceuticals USA, Inc. |
| Busulfan Injection | No longer listed by FDA — Mylan Institutional, A Viatris Company |
| Carbamazepine Capsule, Extended Release | To Be Discontinued — Takeda Pharmaceuticals USA Inc. |
| Peginterferon alfa-2a Injection | Resolved — Pharmaand GmbH (Pharma&) |
| Obeticholic Acid Tablet | No longer listed by FDA — Intercept Pharmaceuticals |
| Lorazepam Injection | Current — Hikma Pharmaceuticals USA, Inc. |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Current — Teva Pharmaceuticals USA, Inc. |
| Dexmedetomidine Hydrochloride Injection | Current — Pfizer Inc. |
| Morphine Sulfate Injection | Current — Hikma Pharmaceuticals USA, Inc. |
| Hydromorphone Hydrochloride Injection | Current — Hospira, Inc., A Pfizer Company |
| Ropivacaine Hydrochloride Injection | Current — Somerset Therapeutics, LLC |
| Everolimus Tablet | To Be Discontinued — Endo Pharmaceuticals, Inc. |
| Bupivacaine Hydrochloride Injection | Current — Eugia US LLC |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Current — Fresenius Kabi USA, LLC |
← Previous
Page 37 of 37